Gina Wood

Gina Wood

Auto-generated profile, based on publicly available information

Gina Wood

Curtin School of Allied Health, Curtin University, Perth, Australia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2019 in BMJ Open Sport & Exercise Medicine
Verified
Journal Article
Open access
PDF file
GWGina Wood
Gina Wood
AMAnna Murrell
Anna Murrell
TTTom van der Touw
Tom van der Touw
NSNeil Smart
Neil Smart
Objective: To compare the effects of moderate intensity continuous training (MICT) and high intensity interval training (HIIT) on adult lipid profiles; to identify training or participant characteristics that may determine exercise-induced change in total cholesterol (TC), triglycerides (TRG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C). Design: Systematic review and meta-analysis. Data sources: English language searches of several databases were conducted from inception until September 2019. Eligibility criteria for excluding studies: Inclusion: (1) published randomised controlled human trials with group population n≥5; (2) intervention duration ≥4 weeks; (3) comparing HIIT with MICT; and (4) reporting pre–post intervention lipid measurements. Exclusion: subjects with chronic disease, <18 years, pregnant/lactating, in elite athletic training; and studies with a dietary or pharmaceutical intervention component. Results: Twenty-nine data sets (mmol/L) of 823 participants were pooled and analysed. Neither HIIT nor MICT was better in decreasing TC (0.10 (−0.06 to 0.19), p=0.12, I2=0%), TRG (−0.05 (−0.11 to 0.01), p=0.10, I2=0%), LDL-C (0.05 (−0.06 to 0.17), p=0.37, I2=0%), or TC/HDL-C (−0.03 (−0.36 to 0.29), p=0.85, I2=0%). HIIT significantly raised HDL-C (0.07 (0.04 to 0.11), p<0.0001, I2=0%) compared with MICT. Conclusion: Neither HIIT nor MICT is superior for altering TC, TRG, or LDL-C, or TC-HDL-C ratio. Compared with MICT, HIIT appeared to significantly improve HDL-C. Clinicians may prescribe either protocol to encourage participation in exercise and reduce cardiovascular risk. To raise HDL-C, HIIT may result in a larger effect size compared with MICT. PROSPERO registration number: CRD42019136722.

30 June 2021 in British Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
GWGina Wood
Gina Wood
ETEmily Taylor
Emily Taylor
VNVanessa Ng
Vanessa Ng
AMAnna Murrell
Anna Murrell
APAditya Patil
Aditya Patil
NSNeil Smart
Neil Smart
Objectives: To estimate the change in the standard lipid profile (SLP) of adults diagnosed with ≥3 metabolic syndrome (MetS) factors following aerobic exercise training (AET); and to investigate whether study/intervention covariates are associated with this change. Design: Systematic review with univariate meta-analysis and meta-regression. Data sources: English language searches of online databases from inception until July 2020. Eligibility criteria: (1) Published randomised controlled human trials with study population ≥10 per group; (2) sedentary adults with ≥3 MetS factors but otherwise free of chronic disease, not pregnant/lactating; (3) AET-only intervention with duration ≥12 weeks; and (4) reporting pre–post intervention SLP outcomes. Results: Various univariate meta-analyses pooled 48 data sets of 2990 participants. Aerobic exercise training significantly (P<.001) improved all lipids (mmol/L mean difference ranges, 95% CIs): total cholesterol, –0.19 (–0.26 to –0.12) to –0.29 (−0.36 to –0.21); triglycerides, −0.17 (–0.19 to –0.14) to –0.18 (−0.24 to –0.13); high-density lipoprotein-cholesterol (HDL-C), 0.05 (0.03 to 0.07) to 0.10 (0.05 to 0.15); and low-density lipoprotein-cholesterol (LDL-C), –0.12 (–0.16 to –0.9) to –0.20 (−0.25 to –0.14). Meta-regression showed that intensity may explain change in triglycerides and volume may explain change in HDL-C and LDL-C. Conclusion: Aerobic exercise training positively changes the SLP of sedentary and otherwise healthy adults with ≥3 MetS factors. Adjusting AET intervention training variables may increase the effects of AET on triglycerides and HDL-C. PROSPERO registration number: CRD42020151925.

2 March 2023 in Sports Medicine
Verified
Journal Article
Open access
PDF file
GWGina Wood
Gina Wood
ETEmily Taylor
Emily Taylor
VNVanessa Ng
Vanessa Ng
AMAnna Murrell
Anna Murrell
APAditya Patil
Aditya Patil
NSNeil A. Smart
Neil A. Smart
Background: Aerobic exercise training (AET) prescribed as lipid management treatment positively affects the standard lipid profile and reduces cardiovascular disease (CVD) risk. Apolipoproteins, lipid and apolipoprotein ratios, and lipoprotein sub-fractions may more effectively predict CVD risk than the standard lipid profile but an AET response in these biomarkers has not been established. Objectives: We conducted a quantitative systematic review of randomised controlled trials (RCTs) to (1) determine the effects of AET on lipoprotein sub-fractions, apolipoproteins and relevant ratios; and (2) identify study or intervention covariates associated with change in these biomarkers. Methods: We searched PubMed, EMBASE, all Web of Science and EBSCO health and medical online databases from inception to 31 December 2021. We included published RCTs of adult humans with ≥ 10 per group of participants; an AET intervention duration ≥ 12 weeks of at least moderate intensity (> 40% maximum oxygen consumption); and reporting pre/post measurements. Non-sedentary subjects, or those with chronic disease other than Metabolic Syndrome factors, or pregnant/lactating, as well as trials testing diet/medications, or resistance/isometric/unconventional training interventions, were excluded. Results: Fifty-seven RCTs totalling 3194 participants were analysed. Multivariate meta-analysis showed AET significantly raised antiatherogenic apolipoproteins and lipoprotein sub-fractions (mmol/L mean difference (MD) 0.047 (95% confidence interval (CI) 0.011, 0.082), P = .01); lowered atherogenic apoliproteins and lipoprotein sub-fractions (mmol/L MD − 0.08 (95% CI − 0.161, 0.0003), P = .05); and improved atherogenic lipid ratios (MD − 0.201 (95% CI − 0.291, − 0.111), P < .0001). Multivariate meta-regression showed intervention variables contributed to change in lipid, sub-fraction, and apoliprotein ratios. Conclusion: Aerobic exercise training positively impacts atherogenic lipid and apolipoprotein ratios, alipoproteins, and lipoprotein sub-fractions; and antiatherogenic apolipoproteins and lipoprotein sub-fractions. Cardiovascular disease risk predicted by these biomarkers may be lowered when AET is prescribed as treatment or prevention. PROSPERO ID: CRD42020151925.

5 April 2024 in Trials
Verified
Journal Article
Open access
PDF file
GWGina Wood
Gina Wood
ASAnna Scheer
Anna Scheer
JSJelena Saundankar
Jelena Saundankar
DTDerek Tran
Derek Tran
RCRachael Cordina
Rachael Cordina
AMAndrew Maiorana
Andrew Maiorana
Background: Accumulated evidence suggests that exercise training exerts beneficial effects on people with congenital heart conditions. These findings are predominantly derived from small, single-centre exercise trials conducted in outpatient rehabilitation facilities. In recent years, the delivery of exercise interventions remotely has increased through digital communications technology (telerehabilitation). However, very little research to date has been conducted into the efficacy of telerehabilitation in people with a congenital heart condition. Aims: To evaluate the effects of a telehealth-delivered exercise intervention in people with a history of a surgical biventricular repair due to a congenital heart condition. Methods: One hundred eligible adolescent (≥ 16 years) and adult participants living with a complex biventricular congenital heart condition will be recruited from four Australian sites and randomised to either (1) a 16-week telehealth-delivered combined (aerobic and resistance) exercise training programme of moderate-to-vigorous intensity or (2) usual care (control group), in a 1:1 allocation, with an 8-month follow-up. Outcomes of interest: The primary outcome will be the change in aerobic capacity expressed as peak oxygen uptake (VO2peak). Secondary outcomes will include changes in vascular function, muscle oxygenation, metabolic profile, body composition and musculoskeletal fitness, neurohormonal activation, neurocognitive function, physical activity levels, dietary and nutritional status, and quality of life. Outcomes will be assessed at baseline, 16 weeks, and 12 months (to determine longer-term maintenance potential). Discussion: If found to be efficacious, telerehabilitation may be an alternative option for delivering exercise, improving health outcomes, and increasing accessibility to exercise programmes. Efficacy data is required to quantify the clinical significance of this delivery mode of exercise. Trial registration: ACTRN12622000050752 Trial registration date: 17 January 2022 Trial registration URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382635&showOriginal=true&isReview=true Trial registry name: Australian and New Zealand Clinical Trials Registry

22 December 2025 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
GWGina Wood
Gina Wood
ASAnna Scheer
Anna Scheer
DTDerek Tran
Derek Tran
RCRachael Cordina
Rachael Cordina
AMAndrew Maiorana
Andrew Maiorana
To determine the effect size of physical activity on clinical outcomes of a cohort comprising adults and adolescents with congenital heart (CH) conditions

29 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
GWGina Wood
Gina Wood
Purpose of review: Six regulatory assessments of the association between paraquat exposure and Parkinson’s disease (PD), conducted 2003-2026, drew on a substantially overlapping body of epidemiological, toxicological, and mechanistic evidence yet reached divergent conclusions. This review examines the selection methodologies, inclusion criteria, and evidence-weighting practices that produced these outcomes. Recent findings: The Australian Pesticides and Veterinary Medicines Authority (APVMA, June 2026) found the evidence it assessed did not convincingly demonstrate a causal association and affirmed paraquat registrations under reduced conditions. The US Environmental Protection Agency (EPA, 2019) found limited but insufficient epidemiological evidence for occupational exposure and insufficient evidence for non-occupational exposure, reopening its paraquat assessment in late 2025 following new volatilisation data. The California Department of Pesticide Regulation (DPR, December 2024) reviewed two of the meta-analyses the APVMA excluded and acknowledged moderate to strong associations in the most recent paraquat-specific study, yet determined that the evidence was insufficient to show a direct causal association. Japan’s Food Safety Commission (FSCJ, 2022) adopted the conclusions of the Joint FAO/WHO Meeting on Pesticide Residues (JMPR, 2003), APVMA (2016), and EPA (2019), as its analytical basis. Brazil’s health regulatory agency (ANVISA, 2017) reached a positive causation finding, prohibited paraquat, and identified specific methodological mechanisms producing the divergence from the APVMA’s 2016 toxicology assessment. The European Union revoked paraquat authorisation in 2007 on procedural grounds. Divergent outcomes are attributable to structural characteristics of the selection process: whether meta-analyses are classified as eligible quantitative evidence; whether differential scrutiny is applied to studies reporting positive and null associations; whether the provenance of key negative studies is disclosed and weighted; and whether data is eligible for scrutiny on the basis of use scope. Summary: Regulatory appraisal criteria applied to complex evidence bases can produce directional bias irrespective of assessment intent. The paraquat-PD case illustrates that methodological choice of data preceding any substantive evaluation of study quality influences the outcome of a weight-of-evidence assessment.